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Background: The presence of clinical Acinetobacter baumannii (A. baumannii) isolates with differing antibiotic
resistance phenotypes in the same patient causes difficulties and confusion in treatment. This phenomenon may be
caused by reasons such as cross-infection from neighboring patients that switches to different A. baumannii strain,
natural mutation of A. baumannii, inducing of different antibiotic resistance genes expression or acquisition of
genes conferring resistance from another source. To elucidate this question, clinical A. baumannii strains, isolated
from the same individual patients, showed antibiotic resistance phenotypes switching during the same
hospitalization period, were attentively collected for further analysis. Molecular approaches for phylogenetic analysis,
including pulsed field gel electrophoresis, multilocus sequence typing, and short tandem repeat analysis, were
employed for the chronological studies.
Findings: Our results showed that antibiotic resistance phenotype switching could have occurred as a result
through both cross-infection and natural mutation roots. Our results also suggest that rapid phenotype switching
between paired isolates could occur during one single course of antibiotic treatment.
Conclusions: Though cross infection caused antibiotic resistance phenotype switching does occur, natural
mutation of A. baumannii isolates is particularly cautious for antibiotic treatment.
Keywords: Acinetobacter baumannii, Pulsed field gel electrophoresis, Multilocus sequence typing, Short tandem
repeat, Phenotype switchFindings
Introduction
Acinetobacter baumannii (A. baumannii ) was identified
from the environment in the early twentieth century, and
has been isolated worldwide. The rapid spread of multidrug-
resistant A. baumannii (MDRAB) in clinical settings has
made choosing an appropriate antibiotic to treat these
infections difficult for clinicians. A. baumannii within
genetically uniform populations exhibit significant pheno-
typic variability [1]. For example, antibiotic susceptible clin-
ical A. baumannii isolates can develop antibiotic resistant
phenotypes, in a process called phenotype switching. Such
phenotype switching can be perplexing for clinicians, in* Correspondence: cchuang@dragon.nchu.edu.tw
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distribution, and reproduction in any mediumboth interpreting microbiological results and choosing
effective antibiotics.
Shanley et al. showed that Acinetobacter calcoaceticus
can naturally uptake, incorporate, and stably maintain
DNA in vitro [2]. Only a few reports have mentioned the
rapid adaptation of A. baumannii isolates in a hospital en-
vironment [3,4]. Determining whether the multiple resist-
ance phenotype switching is due to cross-infection from
neighboring patients or from natural mutation of the same
A. baumannii isolate is important because of the different
strategies needed to resolve the clinical issues. Here we
report the rapid change of resistance phenotype of clinical
A. baumannii isolates from individual patients during the
same admission at a single medical institution in Taiwan.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Isolates and phenotyping
We designed a chronological study to collect pairs of
phenotypically-identified A. baumannii isolates from in-
dividual patients during the same hospitalization period
at Changhua Christian Hospital (CCH). Pool of samples
for further analysis was collected from January 1 1998 to
December 31 2008. Among those samples, there were
three pairs of clinical A. baumannii isolates from CCH
that met the inclusion criteria: Pair 1 (isolates 29-4 and
29-43, numbered according to their position in the CCH
Bacterial Bank), Pair 2 (isolates 10-18 and 10-10), and
Pair 3 (isolates 14-91 and 14-81). Phynotypic method to
identify those A. baumannii isolates is using a Vitek-2
System (BioMerieux, Marcy l'Etoile, France). And, the
isolates were identified according to 16S ribosomal RNA
region at the molecular level, as previously described [5].
DNA isolation, ribotyping, and detection of short tandem
repeats (STR) from clinical A. baumannii isolates
Genomic DNA was isolated from three colonies from an
overnight culture grown on blood agar plates (bioMérieux,
Den Bosch, The Netherlands) using a Bacterial Genomic
DNA Isolation Kit III according to the manufacturer’s
instructions (Roche, Mannheim, Germany). The ribotype
pattern was interpreted to identify the group to which
each strain belonged, as previously described [6]. The
primer pair REP1R-I (5-IIIICGICGICATCIGGC-3) and
REP2-I (5-ICGICTTATCIGGCCTAC-3) [7] was used to
amplify putative REP-like elements from the bacterial
DNA.
Pulsed field gel electrophoresis
We followed a standard protocol for pulsed-field gel
electrophoresis (PFGE) analysis of the A. baumannii iso-
lates. In brief, A. baumannii were plated on blood agar
and incubated in a 5% CO2 atmosphere at 35°C for 16–
24 h. Plug slices were digested with 20 U of SgrAI. The
DNA fragments were then separated in 1% Seakem Gold
agarose gels (FMC BioProducts) at 14°C using a Bio-Rad
CHEF DRIII PFGE system (Bio-Rad Laboratories, Hercules,
CA, USA). Gels were run in 0.5× Tris-borate-EDTA (TBE;
pH 8) at a 120° fixed angle and a fixed voltage (6 V/cm),
with pulse intervals from 4–40 s for 20 h. Following
staining and imaging, the chromosomal DNA restriction
patterns produced by PFGE were interpreted using
Tenover’s categorization [8].
Multilocus sequence typing
Multilocus sequence typing (MLST) was performed ac-
cording to the method of Bartual et al. [9]. In brief, house-
keeping genes for MLST were selected based on their
sequence availability in GenBank, on prior studies of the
phylogenetic relationships for the genus Acinetobacter, andon their use in MLST schemes for other bacterial species
[1,10-12]. PCR primers were chosen from previous studies
or were newly designed for amplification of the seven se-
lected genes: citrate synthase (gltA), DNA gyrase subunit B
(gyrB), glucose dehydrogenase B (gdhB), homologous
recombination factor (recA), 60 kDa chaperonin (cpn60),
glucose-6-phosphate isomerase (gpi), RNA polymerase 70
factor (rpoD). All PCR amplifications were performed in a
MasterCycler gradient instrument (Eppendorf, Hamburg,
Germany). Sequencing of internal fragments (~450 bp in
size) of the selected housekeeping genes was performed in
an ABI Prism 377 sequencer using the ABI Prism BigDye
terminator cycle sequencing ready reaction kit v. 2
(Applied Biosystems, Foster City, CA, USA) according
to the manufacturer’s recommendations.
Results
We collected clinical and microbiological profiles focusing
on the three pairs of A. baumannii isolates from patients
during an individual hospitalization. All three patients
stayed at our institute for at least two weeks, and all of
them received antibiotics following identification of the
A. baumannii isolates (Table 1). The antibiotic susceptibil-
ity of clinical A. baumannii isolates are listed in Table 2.
Four PFGE fingerprint patterns were detected in the three
pairs of A. baumannii isolates in Figure 1. Furthermore,
there appears to be a clear link of cross-infection be-
tween the PFGE types and the clinical data available
for the isolates. Interpretation of the MLST data
revealed that more than half of the MLST allelic
profiles from the three pairs of A. baumannii isolates
differed from those already in A. baumannii MLST
databases (http://pubmlst.org/abaumannii/) [13]. Com-
parison of the sequence types (ST) of the three paired A.
baumannii isolates showed similarity between the 29-4
and 29-43 A. baumannii isolates, especially in the allelic
profiles of gltA, gdhB, recA, and rpoD (Tables 3, 4).
However, there was a difference between the 14-91 and
14-81 paired isolates, especially in the allelic profiles of
recA, cpn60, and rpoD (Tables 3, 4). These results indi-
cated that isolates 29-4 and 29-43 are the same isolate,
and that both paired 14-91 and 14-81 isolates and paired
10-18 and 10-10 isoaltes are different isolates (Tables 3, 4).
The fingerprint patterns of the STRs were quite varied
(Tables 3, 4). It is particularly interesting that rapid pheno-
type switching between the paired isolates (29-4 and 29-
43) could occur during one course of antibiotic treatment.
Discussion
The is the first report of phenotype switching of antibiotic
resistance in clinical A. baumannii isolates in individual
patients during the same hospitalization in Taiwan. While
A. baumannii has been reported previously in Taiwan, and
prolonged administration of broad-spectrum antibiotics
Table 1 The time line of antimicrobial agents prescription
Event Date Patient number one, Pair 1 Date Patient number two, Pair 2 Date Patient number three, Pair 3
Admission day July 29 Admission day July 2 Admission day June 3 Admission day
Antimicrobial agent July 29 and Aug 4 Cefuroxime July 2 and July 19 Ampicillin-sulbactam June 3 and June 10 Ampicillin-sulbactam
Isolation day Aug 2 Isolates 10-10 from sputum July 19 Isolates 29-43 from sputum June 7 Isolates 14-91 from sputum
Antimicrobial agent Aug 4 and Aug 7 Ceftazidime July 19 and July 26 Piperacillin-tazobactam June 10 and June 17 Cefotaxime
Antimicrobial agent Aug 7 and Aug 10 Piperacillin-tazobactam July 26 and Aug 1 Levofloxacin June 17 and June 24 Piperacillin-tazobactam
Antimicrobial agent Since Aug 10 Imipenem-cilastatin Since Aug 1 Imipenem-cilastatin Since June 24 Meropenem
Isolation day Aug 16 Isolates 10-10 from abscess Aug 18 Isolates 29-4 from tip of central catheter July 7 Isolates 14-81 from sputum
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Table 2 Antibiotic susceptibility of clinical Acinetobacter baumannii isolates
Number of isolate 10-10 10-18 29-43 29-4 14-91 14-81
Date of isolation 2-Aug 16-Aug 19-Jul 18-Aug 9-Jun 7-Jul
Time of isolation PM 02:38:55 PM 03:10:10 PM 04:21:03 PM 02:47:06 AM 09:12:47 AM 10:18:53
Diagnosis pneumonia Soft tissue
infection
pneumonia Catheter-related
infection
pneumonia pneumonia
Specimens Sputum, tracheal
aspirate (suction)
abscess Sputum, tracheal
aspirate (suction)
Tip of central catheter Sputum, tracheal
aspirate (suction)
Sputum, tracheal
aspirate (suction)
Antibiotic Minimum inhibitory concentrations (ug/mL)
AN 8 128 8 128 8 64
SAM 32 128 32 128 32 128
CTZ 8 64 8 64 8 32
LVF 2 128 2 128 2 64
IMP 2 16 2 16 2 16
PIP-TAZ 8 256 8 256 8 256
CRO 8 128 8 128 8 64
CFP 8 256 8 256 8 128
MEP 4 32 4 32 4 16
Notes: The susceptibility tests were performed using the Vitek-2 GN card (Biomerieux, Marcy l'Etoile, France). The results were interpreted using the CLSI
breakpoints (Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility testing; Twenty-First Information Supplement.
CLSI document M100-S21, CLSI, Wayne, PA; 2011).
AN: amikacin; SAM: ampicillin-sulbactam; CTZ: ceftazidime; LVF: levofloxacin; IMP: imipenem-cilastatin; PIP-TAZ: piperacillin-tazobactam; CRO: ceftriaxone; CFP:
cefepime; MEP: meropenem; colistin and tigecycline and polymyxin B were not provided by Vitek-2 System.
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clinical A. baumannii isolates, little is known about the
current clinical situation. It was demonstrated that a
important evolutionary change of a single genotype was
fundamental to the continuous rise observed in the
number of A. baumannii infections [4].
The current study suggests that natural transform-
ation and mutation of genotypes occurred in clinicalFigure 1 PFGE fingerprints of three pairs of clinical A. baumannii isolaA. baumannii isolates 29-43 and 29-4 on the basis of
PFGE. We used three methods to determine the genetic
similarity of the paired A. baumannii isolates: PFGE,
MLST, and STR. Snelling et al. described a PCR assay
using repetitive extragenic palindromic sequences to type
A. calcoaceticus and A. baumannii strains [14], while
Alcala et al. characterized a meningococcal epidemic
wave using a MLST method [15], similar to that used intes following digestion with the SgrAI restriction enzyme.
Table 3 The results of pulsed field gel electrophoresis, multilocus sequence typing, and short tandem repeat analysis
of three pairs of A. baumannii isolates
Isolates Geno type(†) PFGE type ST Type(‡) gltA gyrB gdhB recA cpn60 gpi rpoD STR type
10-18 Ab 1 A this study (a1) 6 this study this study this study this study this study this study I
10-10 Ab 2 A this study (a2) 11 this study this study this study this study this study this study II
29-4 Ab 3 B this study (a3) 1 this study 3 2 2 this study 3 III
29-43 Ab 3 B this study (a4) 1 3 3 2 this study 7 3 IX
14-91 Ab 4 C this study (a5) 1 this study this study 2 1 23 18 X
14-81 Ab 5 D this study (a6) 1 this study 3 2 2 this study 3 XI
Notes
Sequences of amplified genes were compared with sequences from the A. baumannii MLST website (http://pubmlst.org/abaumannii/).
ST: sequence type.
† the given name of the genotype is defined as A. baumannii + number (Ab + number).
‡ the given name of the genotype is defined as Acinetobacter isolate + number (a + number).
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and STR data suggests that the findings of the current
study are sound; however, further experiments are required
to prove the relationships among the paired isolates.
In this study, we discovered natural mutation and
rapid change of antibiotic resistance phenotype of clin-
ical A. baumannii isolates from an individual patient.
This is alarming as this particular clone seems to be able
to effectively fill niches that were essentially uninhabited
by A. baumannii in the past. Even in a relatively closed
environment, the isolates of identical PFGE fingerprint
patterns showed a variety of MLST patterns. Apparently,
the MLST patterns of paired isolates 29-4 and 29-43 are
capable of withstanding background mutation. It is possible
that the mutation rate of this particular isolate may contrib-
ute to its success in coping with different environments.Table 4 Aligmnent for three pairs of Acinetobacter baumannii
10-10 VS 10-18 gltA gyrB gdhB
Length 484 927 744
Score 684 1218 1258
Identities 446/484 835/922 699/707
Difference 38 87 8
Gaps 0/484 4/922 4/707
29-4 VS 29-43 gltA gyrB gdhB
Length 484 936 396
Score 894 806 732
Identities 484/484 450/457 396/396
Difference 0 7 0
Gaps 0 0 0
14-91 VS 14-81 gltA gyrB gdhB
Length 484 932 396
Score 894 1701 399
Identities 484/484 924/925 318/369
Difference 0 1 51
Gaps 0 1 0Conclusions
This study provides novel insight into the clinical prob-
lem of whether different A. baumannii isolates from the
same patient are due to cross-infection from neighbor-
ing patients or from natural mutation. This is important
for clinicians because the treatments for the two causes
are different. The approach for the first phenomenon is
to enhance contact precautions in the clinical practice,
whereas the second is the stepwise prescription of differ-
ent antibiotics.
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recA cpn60 gpi rpoD
371 454 358 860
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